FDA approves juxtapid for rare cholesterol disorder

December 27, 2012
FDA approves juxtapid for rare cholesterol disorder
The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia, for use in combination with a low-fat diet and other lipid lowering treatments, according to a Dec. 26 press release.

(HealthDay)—The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia (HoFH), for use in combination with a low-fat diet and other lipid lowering treatments, according to a Dec. 26 press release.

Juxtapid, an orphan drug marketed by Cambridge, Mass.-based Aegerion Pharmaceuticals Inc., was evaluated in a trial including 29 patients with HoFH, an inherited disorder of high low-density lipoprotein (LDL) cholesterol. For those who tolerated the drug, levels of LDL cholesterol decreased by approximately one-half during the first 26 weeks.

Juxtapid, a capsule taken once a day, without food, at least two hours after the evening meal, carries a boxed warning regarding a serious risk of . Juxtapid also decreases the absorption of fat-soluble nutrients and, consequently, patients should take supplements that contain fat-soluble nutrients and essential fatty acids while taking Juxtapid. Juxtapid also interacts with several other medications.

"Juxtapid, in addition to diet changes and other cholesterol-lowering treatments, is a new option for those suffering with HoFH and the serious resulting from this condition," Eric Colman, M.D., deputy director of the Division of Metabolism and Endocrinology Products in the FDA's Center for Drug Evaluation and Research, said in a statement.

Explore further: New medication shows promise as lipid-lowering therapy for rare cholesterol disorder

More information: More Information

Related Stories

New medication shows promise as lipid-lowering therapy for rare cholesterol disorder

November 2, 2012
An international effort led by researchers at the Perelman School of Medicine at the University of Pennsylvania has resulted in positive phase 3 clinical trial results for a new medicine to treat patients suffering from a ...

Consuming cholesterol-lowering foods results in greater decrease in LDL than low-saturated-fat diet

August 23, 2011
Persons with high cholesterol who received counseling regarding a diet that combined cholesterol-lowering foods such as soy protein, nuts and plant sterols over 6 months experienced a greater reduction in their low-density ...

Monthly shot lowers cholesterol 66 percent: study

March 26, 2012
A monthly injection of an experimental drug made by the US biotech firm Amgen reduced patients' cholesterol by up to 66 percent, according to a small study described at a US cardiology conference.

New drug significantly lowers bad cholesterol

November 6, 2012
For many people with high cholesterol, statins serve as the first line of treatment. However, some patients are unable to effectively reduce their low-density lipoprotein cholesterol (LDL cholesterol) or "bad cholesterol" ...

Recommended for you

In most surgery patients, length of opioid prescription, number of refills spell highest risk for misuse

January 17, 2018
The possible link between physicians' opioid prescription patterns and subsequent abuse has occupied the attention of a nation in the throes of an opioid crisis looking for ways to stem what experts have dubbed an epidemic. ...

Patients receive most opioids at the doctor's office, not the ER

January 16, 2018
Around the country, state legislatures and hospitals have tightened emergency room prescribing guidelines for opioids to curb the addiction epidemic, but a new USC study shows that approach diverts attention from the main ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Taking ibuprofen for long periods found to alter human testicular physiology

January 9, 2018
A team of researchers from Denmark and France has found that taking regular doses of the pain reliever ibuprofen over a long period of time can lead to a disorder in men called compensated hypogonadism. In their paper published ...

Nearly one-third of Canadians have used opioids: study

January 9, 2018
Nearly one in three Canadians (29 percent) have used "some form of opioids" in the past five years, according to data released Tuesday as widespread fentanyl overdoses continue to kill.

Growing opioid epidemic forcing more children into foster care

January 8, 2018
The opioid epidemic has become so severe it's considered a national public health emergency. Addiction to prescription painkillers, such as oxycodone and morphine, has contributed to a dramatic rise in overdose deaths and ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.